Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients

Table 1 Clinical characteristics and casual measurements of advanced liver disease outpatients (LD) treated with propranolol or not

Characteristics and measurements	LD with propranolol (n = 9)	LD without propranolol (n = 7)
Age (yrs)	45 ± 2	54 ± 5
Sex male/female	5 (55.6%)/4 (44.4%)	4 (57%)/3 (43%)
Child Pugh Score	9.8 ± 0.5	11.0 ± 0.8
MELD Score	27.1 ± 1.3	29.3 ± 2.1
Albumin (g/dL)	2.7 ± 0.2	2.4 ± 0.3
Bilirubin (mg/dL)	2.5 (1.3-5.1)	2.5 (1.2-7.1)
Creatinine (mg/dL)	1.2 (0.8-2.3)	1.0 (1.0-1.45)
INR (International Normalized Ratio)	1.62 (1.01-6.15)	1.55 (1.20-2.20)
Serum Na+ (mEq/L)	133.0 ± 1.6	126.0 ± 2.7a

Data are expressed as mean ± SE or median (25 and 75 percentile), except for sex where number of patients and percentages are shown.

^aP < 0.05 for the comparison of LD with propranolol and LD without propranolol (unpaired t test for mean comparisons and Mann-Whitney test for median comparisons).